1
Return

Preparation, Characterization, and Leishmanicidal Assessment of Silver- and Dapsone-Loaded Niosomes Co- administration: In Silico and In Vitro Study

delete2024-12-05
delete0
delete
OA
AI
A
Anna Etemadifar
S
Sina Bahraminejad *
A
Abbas Pardakhty
I
Iraj Sharifi
A
Alireza Keyhani
M
Mehdi Ranjbar *
DOI:10.34172/apb.42740delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Purpose: Currently, there is a crucial need for alternative strategies to control leishmaniasis, which threatens more than 1 billion people worldwide. The simultaneous use of combination therapy and nanostructured lipid carriers aimed to assess the leishmanicidal activity of silver and dapsone niosomes co-administration in vitro and in silico. Methods: After preparing the niosomal formulations of dapsone and silver using the film hydration method, Span 40 and Tween 40/cholesterol with a 7/3 molar ratio was selected as the optimal formulation. Consequently, the arrays of experimental approaches were conducted to compare the anti-leishmaniasis efficacy of ready niosomes with amphotericin B and obtain a deeper understanding of their possible mechanisms of action. Results: Our findings showed higher potency of silver-loaded and dapsone-loaded niosomes co-administration compared to amphotericin B as a positive control group. The results of isobologram and combination index (CI) analyses confirmed the synergic potential of this mixture. This combination triggered anti-leishmanial pathways of macrophages, which promoted the expression level of Th1 cell-related genes, and the downregulated expression of the phenotypes related to Th2 cells. Furthermore, a high level of antioxidant and apoptotic profiles against the parasite provides a rational basis and potential drug combination for cutaneous leishmaniasis. Moreover, the outcomes of the molecular docking showed a high binding affinity between dapsone and iNOS, stimulating the immune response in Th1 direction. Conclusion: In general, the multifunctional leishmanicidal activity of dapsone and silverniosomes co-administration should be considered for further in vivo and clinical studies.
Keywords:
Niosomes
Drug delivery
Combination therapy
Cutaneous
leishmaniasis
Dapsone
Silver
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

A
Advanced Pharmaceutical Bulletin
IF:
4.1
Papers:
429
Citations:
3.8K

Organization

K
Kerman University of Medical Sciences
Scholars:
4.3K
Papers: 2.7K
Citations: 3.0K
Cited Papers

Cited Papers

Citing Papers

Citing Papers